These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17058419)

  • 1. Year 2006 update of the National List of Health Services--an endless process.
    Shemer J
    Isr Med Assoc J; 2006 Sep; 8(9):646-8. PubMed ID: 17058419
    [No Abstract]   [Full Text] [Related]  

  • 2. Year 2006 update of the Israel National List of Health Services.
    Tamir O; Rabinovich M; Shani M
    Isr Med Assoc J; 2006 Sep; 8(9):595-600. PubMed ID: 17058406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The process of updating the National List of Health Services in Israel: is it legitimate? Is it fair?
    Greenberg D; Siebzehner MI; Pliskin JS
    Int J Technol Assess Health Care; 2009 Jul; 25(3):255-61. PubMed ID: 19619343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial risk-sharing in updating the National List of Health Services in Israel: stakeholders' perceived interests.
    Hammerman A; Feder-Bubis P; Greenberg D
    Value Health; 2012; 15(5):737-42. PubMed ID: 22867784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Forecasting medical technologies--a global overview].
    Tal O
    Harefuah; 2011 Feb; 150(2):185-9, 202. PubMed ID: 22164951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation for pharmaceuticals in Germany.
    Jönsson B
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
    [No Abstract]   [Full Text] [Related]  

  • 7. A decade to the Israeli Center for Technology Assessment in Health Care.
    Tamir O; Shemer J; Shani M; Vaknin S; Siebzehner MI
    Isr Med Assoc J; 2008 Dec; 10(12):901-5. PubMed ID: 19160954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the budget impact of new technologies added to the National List of Health Services in Israel: stakeholders' incentives for adopting a financial risk-sharing mechanism.
    Hammerman A; Greenberg D
    Health Policy; 2009 Jan; 89(1):78-83. PubMed ID: 18579253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic examination of the 2006/7 update of the Israeli national list of health services].
    Shmueli A; Nissan-Englcin E
    Harefuah; 2008 Jun; 147(6):488-92, 576. PubMed ID: 18693622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment for radiologists: basic principles and evaluation framework.
    Lim ME; O'Reilly D; Tarride JE; Burke N; Ferrusi IL; Campbell K; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):299-306. PubMed ID: 19394570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus conference as a tool for national health services policy: the case for osteoporosis.
    Shemer J
    Isr Med Assoc J; 2000 May; 2(5):375-6. PubMed ID: 10892394
    [No Abstract]   [Full Text] [Related]  

  • 12. Health technology assessment from a Canadian device industry perspective.
    Ferrusi IL; Ames D; Lim ME; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selecting medical devices and materials for development in Korea: the analytic hierarchy process approach.
    Cho KT; Kim SM
    Int J Health Plann Manage; 2003; 18(2):161-74. PubMed ID: 12841155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing face of health technology assessment.
    Hillman BJ
    J Am Coll Radiol; 2009 May; 6(5):289. PubMed ID: 19394565
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction: health technology assessment in diagnostic imaging.
    Carlos RC; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):297-8. PubMed ID: 19394569
    [No Abstract]   [Full Text] [Related]  

  • 17. Health technology assessment: a review of international activity and examples of approaches with computed tomographic colonography.
    Husereau D; Morrison A; Battista R; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):343-52. PubMed ID: 19394575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging health technologies: informing and supporting health policy early.
    Wild C; Langer T
    Health Policy; 2008 Aug; 87(2):160-71. PubMed ID: 18295925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sustainability of Canada's healthcare system: a framework for advancing the debate. Commentary.
    Lewis S
    Healthc Q; 2007; 10(2):103-4; author reply 105-6. PubMed ID: 18271107
    [No Abstract]   [Full Text] [Related]  

  • 20. Methods for determining cost-benefit ratios for pharmaceuticals in Germany.
    von der Schulenburg J; Vauth C; Mittendorf T; Greiner W
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S5-31. PubMed ID: 17582539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.